In a recent IQVIA webinar, ‘Partnering with the NHS in a crisis’, representative experts from the life sciences industry and the NHS explored why collaboration between the two is more criti
Primary care doctors in the UK are a “negligible” provider of commercial clinical trial activity and should be incentivised to give experimental therapies to patients.
Dr Fabrizio Calisti and Dr Thomas Thestrup of Angelini Ventures discuss how their unique medical and scientific knowledge help infuse subject matter expertise and patient insights into the
